Sales rise 35.82% to Rs 75.41 crore
Net profit of Marksans Pharma declined 53.52% to Rs 1.32 crore in the quarter ended September 2017 as against Rs 2.84 crore during the previous quarter ended September 2016. Sales rose 35.82% to Rs 75.41 crore in the quarter ended September 2017 as against Rs 55.52 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales75.4155.52 36 OPM %8.43-0.65 -PBDT3.865.75 -33 PBT0.552.00 -73 NP1.322.84 -54Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
